Rebif Drug Interactions
Links shared publicly online about this topic
Doctors Alleged to Have Been Paid to Prescribe Multiple Sclerosis Drug Rebif
disabled-world.com — “Allegations a company caused false or fraudulent claims to be submitted to the Medicaid program” View full resource at disabled-world.com
Most Recently Shared on May 13, 2011 at 10:25 pm By:
Disabled World Health Advocate and Health News
Doctors Alleged to Have Been Paid to Prescribe Multiple Sclerosis Drug Rebif http://ff.im/-DiXm7
Genzyme MS drug shines in head-to-head trial with Rebif | InPharm
inpharm.com — “Genzyme--™s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial” View full resource at inpharm.com
Most Recently Shared on April 18, 2011 at 9:53 am By:
Pharmafocus Health News and Pharma
Genzyme MS drug shines in head-to-head trial with Rebif http://goo.gl/fb/6yK45
PharmaLive: Prime Therapeutics Announces CareCentered Contract with EMD Serono, Inc. for MS Drug Rebif
pharmalive.com — “PharmaLive: Prime Therapeutics Announces CareCentered Contract with EMD Serono, Inc. for MS Drug Rebif” View full resource at pharmalive.com
Most Recently Shared on March 12, 2012 at 3:52 pm By:
Kathleen Starr, Ph.D PhD, Doctor, and Psychologist
Outcomes based contracting: Prime Ther. Announces CareCentered Contract with EMD Serono for MS Drug http://t.co/BOS6CDL6 @myen #pharma #in
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk
medicalnewstoday.com — “Although Lemtrada (alemtuzumab) was found to be more effective in preventing MS relapses than the older drug - Rebif - it did not prevent multiple sclerosis (MS) from becoming disabling in a late-” View full resource at medicalnewstoday.com
Most Recently Shared on July 11, 2011 at 7:05 pm By:
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk http://mnt.to/3Y8Z #multiplesclerosis
REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs of the Disease - Drugs.com MedNews
drugs.com — “Study met its primary endpoint Risk of converting to multiple sclerosis (McDonald criteria) was reduced by half in patients treated with Rebif 44 mcg three time” View full resource at drugs.com
Most Recently Shared on October 25, 2010 at 2:12 pm By:
Drugs and Devices OW OW Health
REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs ... http://bit.ly/bzTgZJ #drug
Drug company Serono settles lawsuit alleging it paid doctors to prescribe - CBS News Investigates - CBS News
cbsnews.com — “Lawsuit alleges drug giant Serono paid doctors to prescribe Rebif Read more by Laura Strickler on CBS News' CBS News Investigates.” View full resource at cbsnews.com
Most Recently Shared on May 5, 2011 at 10:31 pm By:
George Jelinek Doctor, Emergency Physician, and Physician
Drug company settles for $44m for sending money to doctors to prescribe Rebif in MS http://bit.ly/kflaIc
Medications for MS: What--™s the difference between interferon beta-1a and interferon beta-1b? - Multiple Sclerosis
healthcentral.com — “Four of the seven currently available disease-modifying MS drugs are often referred to as “the interferons” - Avonex, Rebif, Betaseron, and Extavia....” View full resource at healthcentral.com
Most Recently Shared on December 1, 2010 at 4:36 pm By:
Medications for MS: What's the difference between interferon beta-1a and interferon beta-1b? http://ow.ly/1afB1E
Multiple Sclerosis Drug Produces Positive Trial Results | ThirdAge
thirdage.com — “Multiple sclerosis drug Lemtrada showed a greater reduction rate in relapse compared with Merck KGaA's MS drug Rebif” View full resource at thirdage.com
Most Recently Shared on July 11, 2011 at 5:04 pm By:
Multiple Sclerosis Drug Produces Positive Trial Results: The multiple sclerosis (MS) drug Lemtrada produced posi... http://bit.ly/mYwe2F
Merck FY2010 Profit After Tax Climbs 70% to EUR 642 Million - Drugs.com MedNews
drugs.com — “Total revenues increase 20 to record EUR 9.3 billion Operating result jumps 72 to EUR 1.1 billion Sales Rebif 8.6 (EUR 1,668 million) Erbitux 18 (EUR 820 millio” View full resource at drugs.com
Most Recently Shared on February 22, 2011 at 4:10 pm By:
Drugs and Devices OW OW Health
Merck FY2010 Profit After Tax Climbs 70% to EUR 642 Million: Total revenues increase 20% to record EUR 9.3... http://bit.ly/e6NzfS #drug
How M.S. Drugs Are Promoted: “We Have a Whole Money Laundering Thing Going On” | BNET
bnet.com — “Serono Labs allegedly had a “money laundering” operation that “funneled” funds via a charity to doctors who prescribed Rebif,” View full resource at bnet.com
Most Recently Shared on May 6, 2011 at 12:55 pm By:
Jim Edwards Health Communicator
How M.S. Drugs Are Promoted: "We Have a Whole Money Laundering Thing Going On": Serono Labs allegedly had a "mon... http://bit.ly/k6CT7W
Drug Interactions
medicinenet.com — “Explains the medication lisinopril (Zestril, Prinivil) an ACE inhibitor drug used to treat elevated blood pressure and heart failure.” View full resource at medicinenet.com
Most Recently Shared on June 4, 2009 at 11:07 pm By:
MedicineNet: lisinopril, Zestril, Prinivil http://bit.ly/em8LlR Full http://bit.ly/fJhzua
Heath Ledger's Drug Interactions
healthline.com — “Heath Ledger's Drug Interactions” View full resource at healthline.com
Most Recently Shared on February 7, 2008 at 8:46 am By:
Joshua Schwimmer Doctor, Internist, Nephrologist, and Physician
Tech Medicine: Heath Ledger's Drug Interactions http://tinyurl.com/3xas6s
Drug Interaction? | Ask the Therapist
psychcentral.com — “I have been on generic Zoloft for years with fairly good results. Within the last 6 months, I had a complete thyroidectomy and am now on levothyroxine. Can” View full resource at psychcentral.com
Most Recently Shared on February 18, 2010 at 10:27 am By:
Ask the Therapist: Drug Interaction? http://bit.ly/9tBLX8
Merck Serono Submits Application For Extension Of Indication For Rebif(R) In Europe
medicalnewstoday.com — “Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an application to the European Medicines Agency (EMA) to extend the indication of Rebif®, its” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2011 at 9:05 am By:
Merck Serono Submits Application For Extension Of Indication For Rebif(R) In Europe http://mnt.to/3XMv #multiplesclerosis
Interactive Media
fda.gov — “A listing of videos, podcasts, blogs, widgets and more that are available from FDA.” View full resource at fda.gov
Most Recently Shared on June 15, 2010 at 8:20 pm By:
FDA's #interactive #media page; includes video, audio, social media links, etc. http://ow.ly/1YSrH
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
-
Kathleen Starr, Ph.D
Health Psychologist. Integrating science of behavior change with health & medical marketing. Passionate @ engaging, inspiring & providing tools for change.
Advertisement
